Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2011-05-09 16:18:25
Reporting Period:
Filing Date:
Filing Date Changed:
Accepted Time:
2011-05-09 17:18:25
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
786947 Acura Pharmaceuticals, Inc ACUR Pharmaceutical Preparations (2834) 110853640
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1058352 G William Skelly C/o Acura Pharmaceuticals, Inc.
616 N. North Court
Palatine IL 60067
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stiock Disposition 2011-05-09 5,000 $4.27 90,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
  1. Amount of securities include 75,000 remaining Restricted Stock Units held by Reporting Person. Absent a change of control, shares of common stock will be distributed in exchange for Restricted Stock Units (after payment of $.01 par value per share) in three equal installments on January 1st of each of 2012, 2013 and 2014.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!